Army Liposome Formulation (ALF) Phase 2 and 3 Clinical Trials

Inactive
Notice ID:HT942524Q0107

Please see Solicitation Amendment HT9425-24-Q-0107 -00002 document to provide complete answers to all questions received.

Department/Ind.Agency Subtier Office
DEPT OF DEFENSE DEFENSE HEALTH AGENCY (DHA) ARMY MED RES ACQ ACTIVITY
  PSC   PHARMACOLOGY SERVICES


Data sourced from SAM.gov. View Official Posting »